Wassim Fares's most recent trade in Bellerophon Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 10, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Wassim Fares | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Bellerophon Therapeutics Inc | Wassim Fares | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 10.18 per share. | 10 Sep 2020 | 4,000 | 4,000 (0%) | 0% | 10.2 | 40,708 | Common Stock |